Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for recurrent implantation failure in women undergoing assisted reproduction
IRCT20151004024335N6Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydroxychloroquine in female infertility and Recurrent Implantation Failure (RIF), sponsored by Kerman University of Medical Sciences. Started May 2025; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
female infertilityRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20151004024335N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151004024335N6.